Free Content Eosinophil Cationic Protein Stimulates Migration of Human Lung Fibroblasts In Vitro

Authors: Zagai, U.1; Lundahl, J.2; Klominek, J.3; Venge, P.4; Sköld, C. M.1

Source: Scandinavian Journal of Immunology, Volume 69, Number 4, April 2009 , pp. 381-386(6)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Asthma is characterized by eosinophilic inflammation and remodelling of the airways. Eosinophil cationic protein (ECP) is a protein released by activated eosinophils and the hypothesis that ECP contributes to the development of structural changes in the airways of asthmatics has been posed. Fibroblast recruitment is an important step in the remodelling process, and we therefore put the question whether ECP stimulates migration of human lung fibroblasts. Human peripheral eosinophils isolated from buffycoats from healthy individuals were cultured and conditioned media (CM) were collected. Native ECP was extracted from human peripheral eosinophils by gel filtration, ion-exchange and chelating chromatography. The ability of eosinophil CM and ECP to stimulate fibroblast migration was determined using the 48-well Boyden chamber. ECP concentrations in CM were assayed by ECP-CAP-FEIA. Both CM and ECP significantly stimulated fibroblast migration (48.4 ± cells/field versus 33 ± 2 and 36 ± 6 versus 25 ± 4; P < 0.001 and 0.05 respectively) in a time- and concentration-dependent manner. Adding neutralizing ECP antibodies attenuated fibroblast migration induced by both ECP as well as CM. ECP stimulates migration of human lung fibroblasts, suggesting a potential mechanism for eosinophils in the fibrotic response. This may be an important mechanism by which ECP promotes remodelling of extracellular matrix leading to airway fibrosis in asthmatics.

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-3083.2009.02233.x

Affiliations: 1: Department of Medicine, Division of Respiratory Medicine, Karolinska Institutet, Stockholm 2: Department of Medicine, Division of Clinical Immunology & Allergy, Karolinska Institutet, Stockholm 3: Department of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Huddinge 4: Department of Medical Sciences, Clinical Chemistry, University of Uppsala, Uppsala, Sweden

Publication date: 2009-04-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page